{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:05:20Z","timestamp":1779530720590,"version":"3.53.1"},"reference-count":56,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Autoimmune Thyroiditis (AIT) is caused by defects in the immune system\nin people with a genetic predisposition to the disease. The most prevalent type of autoimmune\nthyroiditis is Hashimoto's thyroiditis (HT). The present article reviews the possible relationship between\n\u03b12-macroglobulin levels and autoantibodies in patients suffering from Hashimoto's disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 170 patients with Hashimoto's disease, categorized into subclinical (96 patients)\nand manifest (74 patients) forms, were enrolled in the study. The control group comprised\n65 individuals without thyroid pathologies or other autoimmune diseases. The levels of \u03b12-macroglobulin\nand autoantibodies, including both organ-specific and non-organ-specific, were determined\nin all study participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Organ-specific antibody and \u03b12-macroglobulin levels were elevated in all patients\nstudied compared to controls. Analysis of organ non-specific antibody levels in patients revealed\nelevated levels of antibodies to double-stranded (native) DNA in both the subclinical and manifest\ngroups of patients. There were no statistically significant differences in antibody levels to single-stranded\n(denatured) DNA between the total patient group and the control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The data obtained demonstrated that there is no significant correlation between \u03b12--\nmacroglobulin levels and autoantibody titres, as well as the severity of autoimmune thyroiditis.\nThis finding suggests that \u03b12-macroglobulin may have an unlikely role in the pathogenesis or as a\nbiomarker of disease activity, including in the presence of antibody-dependent cellular damage.\nConversely, antibodies directed against double-stranded DNA have exhibited enhanced informativeness\nand can be regarded as potential markers of the severity of autoimmune thyroid lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Consequently, \u03b12-macroglobulin has no diagnostic value as an indicator of autoimmune\nprocess exacerbation in Hashimoto's thyroiditis. Conversely, the presence and level of antibodies\nto double-stranded DNA may offer a means to assess the severity of the disease and should\nbe the focus of further studies as prognostic markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892037374562250730060143","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:35:45Z","timestamp":1757338545000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Various Autoantibodies and Alpha2-Macroglobulin in Patients with Hashimoto Disease: Does the Presence of Elevated Antibodies Correlate with Alpha 2-Macroglobulin Levels in Hashimoto Disease?"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6080-0622","authenticated-orcid":true,"given":"Rena","family":"Rahimova","sequence":"first","affiliation":[{"name":"Azerbaijan Medical University, Baku, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara","family":"Azizova","sequence":"additional","affiliation":[{"name":"Azerbaijan Medical University, Baku, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3368-1124","authenticated-orcid":true,"given":"Ilaha","family":"Shahverdiyeva","sequence":"additional","affiliation":[{"name":"Azerbaijan Medical University, Baku, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-3559","authenticated-orcid":true,"given":"Gulnara","family":"Dashdamirova","sequence":"additional","affiliation":[{"name":"Azerbaijan Medical University, Baku, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1740-625X","authenticated-orcid":true,"given":"Michael","family":"Mehdiyev","sequence":"additional","affiliation":[{"name":"Fort Lee High School, Fort Lee, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","volume":"33","author":"Ragusa F","year":"2019","unstructured":"Ragusa F; Fallahi P; Elia G.; Hashimoto's thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab  2019,33(6),101367","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3934\/medsci.2023002","volume":"10","author":"Rahimova R.","year":"2023","unstructured":"Rahimova R.; Relationship between CTLA4, TNF-\u03b1 and PTPN22 gene polymorphism and the serum levels of antithyroglobulin and antiperoxidase antibodies in autoimmune thyroiditis. AIMS Med Sci  2023,10(1),14-23","journal-title":"AIMS Med Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/13813455.2017.1408660","volume":"124","author":"Ates I.","year":"2018","unstructured":"Ates I.; Arikan M.F.; Altay M.; Yilmaz F.M.; Yilmaz N.; Berker D.; Guler S.; The effect of oxidative stress on the progression of Hashimoto\u2019s thyroiditis. Arch Physiol Biochem  2018,124(4),351-356","journal-title":"Arch Physiol Biochem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000363162","volume":"26","author":"Radetti G.","year":"2014","unstructured":"Radetti G.; Clinical aspects of Hashimoto\u2019s thyroiditis. Endocr Dev  2014,26,158-170","journal-title":"Endocr Dev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/antib12030048","volume":"12","author":"Vargas-Uricoechea H.","year":"2023","unstructured":"Vargas-Uricoechea H.; Nogueira J.P.; Pinz\u00f3n-Fern\u00e1ndez M.V.; Schwarzstein D.; The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease. Antibodies  2023,12(3),48","journal-title":"Antibodies"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40618-020-01492-2","volume":"44","author":"Mancino G.","year":"2021","unstructured":"Mancino G.; Miro C.; Di Cicco E.; Dentice M.; Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin. J Endocrinol Invest  2021,44(8),1571-1579","journal-title":"J Endocrinol Invest"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/thy.2022.0491","volume":"33","author":"Fenneman A. C.","year":"2023","unstructured":"Fenneman A. C.; Bruinstroop E.; Nieuwdorp M.; van der Spek A. H.; Boelen A.; A comprehensive review of thyroid hormone metabolism in the gut and its clinical implications. Thyroid  2023,33(1),32-44","journal-title":"Thyroid"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/1744666X.4.2.221","volume":"4","author":"Takasu N.","year":"2008","unstructured":"Takasu N.; Yoshimura Noh J.; Hashimoto\u2019s thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism. Expert Rev Clin Immunol  2008,4(2),221-237","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=9","first-page":"31","volume":"42","author":"Umar H.","year":"2010","unstructured":"Umar H.; Muallima N.; Adam J.M.; Sanusi H.; Hashimoto\u2019s thyroiditis following Graves\u2019 disease. Acta Med Indones  2010,42(1),31-35","journal-title":"Acta Med Indones"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1507\/endocrj.EJ17-0164","volume":"64","author":"Nishihara E.","year":"2017","unstructured":"Nishihara E.; Amino N.; Kudo T.; Ito M.; Fukata S.; Nishikawa M.; Nakamura H.; Miyauchi A.; Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases. Endocr J  2017,64(10),955-961","journal-title":"Endocr J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jaci.2023.02.008","volume":"151","author":"Skevaki C.","year":"2023","unstructured":"Skevaki C.; Wesemann D.R.; Antibody repertoire and autoimmunity. J Allergy Clin Immunol  2023,151(4),898-900","journal-title":"J Allergy Clin Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/thy.2016.0635","volume":"27","author":"Hu S.","year":"2017","unstructured":"Hu S.; Rayman M. P.; Multiple nutritional factors and the risk of Hashimoto's thyroiditis. Thyroid  2017,27(5),597-610","journal-title":"Thyroid"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.31083\/j.fbl2710297","volume":"27","author":"Jin B.","year":"2022","unstructured":"Jin B.; Wang S.; Pathogenesis markers of Hashimoto's disease\u2014A mini review. Front Biosci  2022,27(10),297","journal-title":"Front Biosci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/ijms23095227","volume":"23","author":"Pisetsky D.S.","year":"2022","unstructured":"Pisetsky D.S.; Garza Reyna A.; Belina M.E.; Spencer D.M.; The interaction of anti-DNA antibodies with DNA: Evidence for unconventional binding mechanisms. Int J Mol Sci  2022,23(9),5227","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-2005-873005","volume":"114","author":"Pedro A.","year":"2006","unstructured":"Pedro A.; Romaldini J.; Americo C.; Takei K.; Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves\u2019 disease and Hashimoto\u2019s thyroiditis patients. Exp Clin Endocrinol Diabetes  2006,114(1),35-38","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1368088","DOI":"10.3389\/fendo.2024.1368088","volume":"15","author":"Ruan Y.","year":"2024","unstructured":"Ruan Y.; Heng X.; Yang L.; He W.; Li L.; Wang Z.; Huang S.; Chen Q.; Han Z.; Relationship between autoimmune thyroid antibodies and anti-nuclear antibodies in general patients. Front Endocrinol  2024,15,1368088","journal-title":"Front Endocrinol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35630\/2023\/13\/3.309","volume":"13","author":"Rahimova R.","year":"2023","unstructured":"Rahimova R.; Dashdamirova G.; Shahverdiyeva I.; Yagubova V.; Bayramova N.; Neuroendocrine and immune interaction in autoimmune thyroiditis. Arch Euromedica  2023,13(3),1-7","journal-title":"Arch Euromedica"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41584-021-00573-7","volume":"17","author":"Granito A.","year":"2021","unstructured":"Granito A.; Muratori L.; Tovoli F.; Muratori P.; Diagnostic role of anti-dsDNA antibodies: Do not forget autoimmune hepatitis. Nat Rev Rheumatol  2021,17(4),244","journal-title":"Nat Rev Rheumatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40618-020-01477-1","volume":"44","author":"Weetman A.P.","year":"2021","unstructured":"Weetman A.P.; An update on the pathogenesis of Hashimoto\u2019s thyroiditis. J Endocrinol Invest  2021,44(5),883-890","journal-title":"J Endocrinol Invest"},{"key":"ref=20","author":"Mincer D.L.","year":"2024","unstructured":"Mincer D.L.; Jialal I.; Hashimoto Thyroiditis. StatPearls  2024","journal-title":"StatPearls"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/150239","volume":"2014","author":"Segni M.","year":"2014","unstructured":"Segni M.; Pucarelli I.; Truglia S.; Turriziani I.; Serafinelli C.; Conti F.; High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res  2014,2014,1-6","journal-title":"J Immunol Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6895146","volume":"2018","author":"Siriwardhane T.","year":"2018","unstructured":"Siriwardhane T.; Krishna K.; Ranganathan V.; Jayaraman V.; Wang T.; Bei K.; Rajasekaran J.J.; Krishnamurthy H.; Exploring systemic autoimmunity in thyroid disease subjects. J Immunol Res  2018,2018,1-7","journal-title":"J Immunol Res"},{"key":"ref=23","author":"Franco J.S.","year":"2013","unstructured":"Franco J.S.; Amaya-Amaya J.; Anaya J.; Chapter 30 M. Thyroid disease and autoimmune diseases. Autoimmunity: From Bench to Bedside  2013","journal-title":"Autoimmunity: From Bench to Bedside"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.3390\/ijms25136883","volume":"25","author":"Wro\u0144ska K.","year":"2024","unstructured":"Wro\u0144ska K.; Ha\u0142asa M.; Szczuko M.; The role of the immune system in the course of hashimoto\u2019s thyroiditis: The current state of knowledge. Int J Mol Sci  2024,25(13),6883","journal-title":"Int J Mol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41467-022-28120-2","volume":"13","author":"Zhang Q.Y.","year":"2022","unstructured":"Zhang Q.Y.; Ye X.P.; Zhou Z.; Zhu C.F.; Li R.; Fang Y.; Zhang R.J.; Li L.; Liu W.; Wang Z.; Song S.Y.; Lu S.Y.; Zhao S.X.; Lin J.N.; Song H.D.; Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto\u2019s thyroiditis. Nat Commun  2022,13(1),775","journal-title":"Nat Commun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"803244","DOI":"10.3389\/fimmu.2021.803244","volume":"12","author":"Vandooren J.","year":"2021","unstructured":"Vandooren J.; Itoh Y.; Alpha-2-macroglobulin in inflammation, immunity and infections. Front Immunol  2021,12(Dec),803244","journal-title":"Front Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1334772","DOI":"10.3389\/fimmu.2024.1334772","volume":"15","author":"Yao Z.","year":"2024","unstructured":"Yao Z.; Guo F.; Tan Y.; Zhang Y.; Geng Y.; Yang G.; Wang S.; Causal relationship between inflammatory cytokines and autoimmune thyroid disease: A bidirectional two-sample Mendelian randomization analysis. Front Immunol  2024,15,1334772","journal-title":"Front Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/979167","volume":"2015","author":"Pyzik A.","year":"2015","unstructured":"Pyzik A.; Grywalska E.; Matyjaszek-Matuszek B.; Roli\u0144ski J.; Immune disorders in Hashimoto\u2019s thyroiditis: What do we know so far? J Immunol Res  2015,2015,1-8","journal-title":"J Immunol Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"7744","DOI":"10.4081\/thal.2018.7744","volume":"8","author":"Efendiyev A.M.","year":"2018","unstructured":"Efendiyev A.M.; Azizova G.I.; Dadashova A.R.; Investigation of some endogenous antimicrobial peptides in thalassemia. Thalassemia Reports  2018,8(2),7744","journal-title":"Thalassemia Reports"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"Marshall J.S.","year":"2018","unstructured":"Marshall J.S.; Warrington R.; Watson W.; Kim H.L.; An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol  2018,14(S2),49","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/medicina45070076","volume":"45","author":"Paknys G.","year":"2009","unstructured":"Paknys G.; Kondrotas A.J.; Kevelaitis E.; Hasimoto tiroidito rizikos veiksniai ir patogeneze. Medicina  2009,45(7),574-583","journal-title":"Medicina"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5410657","volume":"2019","author":"Cater J.H.","year":"2019","unstructured":"Cater J.H.; Wilson M.R.; Wyatt A.R.; Alpha-2-macroglobulin, a hypochlorite-regulated chaperone and immune system modulator. Oxid Med Cell Longev  2019,2019,1-9","journal-title":"Oxid Med Cell Longev"},{"key":"ref=33","author":"Gulhar R.","year":"2024","unstructured":"Gulhar R.; Ashraf M.A.; Jialal I.; Physiology, acute phase reactants. StatPearls  2024","journal-title":"StatPearls"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijbiomac.2018.05.112","volume":"117","author":"Siddiqui T.","year":"2018","unstructured":"Siddiqui T.; Zia M.K.; Ali S.S.; Ahsan H.; Khan F.H.; Insight into the interactions of proteinase inhibitor- alpha-2-macroglobulin with hypochlorite. Int J Biol Macromol  2018,117,401-406","journal-title":"Int J Biol Macromol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/cge.13088","volume":"93","author":"G\u00e1mez A.","year":"2018","unstructured":"G\u00e1mez A.; Yuste-Checa P.; Brasil S.; Briso-Montiano \u00c1.; Desviat L.R.; Ugarte M.; P\u00e9rez-Cerd\u00e1 C.; P\u00e9rez B.; Protein misfolding diseases: Prospects of pharmacological treatment. Clin Genet  2018,93(3),450-458","journal-title":"Clin Genet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-3-319-46503-6_6","volume":"83","author":"Garcia-Ferrer I.","year":"2017","unstructured":"Garcia-Ferrer I.; Marrero A.; Gomis-R\u00fcth F.X.; Goulas T.; \u03b1-Macroglobulins: Structure and function. Subcell Biochem  2017,83,149-183","journal-title":"Subcell Biochem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"110638","DOI":"10.1016\/j.mce.2019.110638","volume":"501","author":"Targovnik H.M.","year":"2020","unstructured":"Targovnik H.M.; Scheps K.G.; Rivolta C.M.; Defects in protein folding in congenital hypothyroidism. Mol Cell Endocrinol  2020,501,110638","journal-title":"Mol Cell Endocrinol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/diseases11010030","volume":"11","author":"Ajmal M.R.","year":"2023","unstructured":"Ajmal M.R.; Protein misfolding and aggregation in proteinopathies: Causes, mechanism and cellular response. Diseases  2023,11(1),30","journal-title":"Diseases"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/diseases11010015","volume":"11","author":"Erge E.","year":"2023","unstructured":"Erge E.; Kiziltunc C.; Balci S.B.; Atak Tel B.M.; Bilgin S.; Duman T.T.; Aktas G.; A novel inflammatory marker for the diagnosis of hashimoto\u2019s thyroiditis: Platelet-count-to-lymphocyte-count ratio. Diseases  2023,11(1),15","journal-title":"Diseases"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"Merle N.S.","year":"2015","unstructured":"Merle N.S.; Church S.E.; Fremeaux-Bacchi V.; Roumenina L.T.; Complement system part I \u00e2\u20ac\u201c molecular mechanisms of activation and regulation. Front Immunol  2015,6,262","journal-title":"Front Immunol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/jcp.24266","volume":"228","author":"Rehman A.A.","year":"2013","unstructured":"Rehman A.A.; Ahsan H.; Khan F.H.; \u03b1-2-macroglobulin: A physiological guardian. J Cell Physiol  2013,228(8),1665-1675","journal-title":"J Cell Physiol"},{"key":"ref=42","first-page":"51","volume":"37","author":"Wallace D.F.","year":"2016","unstructured":"Wallace D.F.; The regulation of iron absorption and homeostasis. Clin Biochem Rev  2016,37(2),51-62","journal-title":"Clin Biochem Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000235782","volume":"64","author":"Thornton C.A.","year":"2009","unstructured":"Thornton C.A.; Morgan G.; Innate and adaptive immune pathways to tolerance. Nestle Nutr Inst Workshop Ser  2009,64,45-61","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3390\/nu14214682","volume":"14","author":"Szklarz M.","year":"2022","unstructured":"Szklarz M.; Gontarz-Nowak K.; Matuszewski W.; Bandurska-Stankiewicz E.; Iron: Not Just a Passive Bystander in AITD. Nutrients  2022,14(21),4682","journal-title":"Nutrients"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/03007995.2020.1748585","volume":"36","author":"Chang R.","year":"2020","unstructured":"Chang R.; Chu K.A.; Lin M.C.; Chu Y.H.; Hung Y.M.; Wei J.C.C.; Newly diagnosed iron deficiency anemia and subsequent autoimmune disease: A matched cohort study in Taiwan. Curr Med Res Opin  2020,36(6),985-992","journal-title":"Curr Med Res Opin"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1017\/S0029665118001192","volume":"78","author":"Rayman M.P.","year":"2019","unstructured":"Rayman M.P.; Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc Nutr Soc  2019,78(1),34-44","journal-title":"Proc Nutr Soc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2023.06.17.545408","DOI":"10.1101\/2023.06.17.545408","author":"Monko T.R.","year":"2023","unstructured":"Monko T.R.; Tripp E.H.; Burr S.E.; Gunderson K.N.; Lanier L.M.; Georgieff M.K.; Bastian T.W.; Cellular iron deficiency disrupts thyroid hormone regulated gene expression in developing hippocampal neurons. bioRxiv  2023,2023.06.17.545408","journal-title":"bioRxiv"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"0142615","DOI":"10.1371\/journal.pone.0142615","volume":"10","author":"Le S.N.","year":"2015","unstructured":"Le S.N.; Porebski B.T.; McCoey J.; Fodor J.; Riley B.; Godlewska M.; G\u00f3ra M.; Czarnocka B.; Banga J.P.; Hoke D.E.; Kass I.; Buckle A.M.; Modelling of thyroid peroxidase reveals insights into its enzyme function and autoantigenicity. PLoS One  2015,10(12),0142615","journal-title":"PLoS One"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.15407\/ubj94.02.051","volume":"94","author":"Rahimova R.R.","year":"2022","unstructured":"Rahimova R.R.; Study of matrix metalloproteinase activity in patients with autoimmune thyroiditis. Ukr Biochem J  2022,94(2),51-56","journal-title":"Ukr Biochem J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1080\/07391102.2019.1623073","volume":"38","author":"Malik H.I.","year":"2020","unstructured":"Malik H.I.; Mir A.R.; Abidi M.; Habib S.; Khan F.H.; Moinuddin ; . Preferential recognition of epitopes on peroxynitrite-modified alpha-2-macroglobulin by circulating autoantibodies in rheumatoid arthritis patients. J Biomol Struct Dyn  2020,38(7),1984-1994","journal-title":"J Biomol Struct Dyn"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14341\/probl201460610-13","volume":"60","author":"Maklakova T.P.","year":"2014","unstructured":"Maklakova T.P.; Zorina V.N.; Shapel\u2019 T.T.; Boiko O.N.; Zorina R.M.; Zorin N.A.; The levels of immunoreactive proteins and cytokines in the blood of the patients presenting with autoimmune thyroid diseases. Prob Endokrinol  2014,60(6),1-6","journal-title":"Prob Endokrinol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3389\/fimmu.2017.00759","volume":"8","author":"Shokal U.","year":"2017","unstructured":"Shokal U.; Eleftherianos I.; Evolution and function of thioester-containing proteins and the complement system in the innate immune response. Front Immunol  2017,8,759","journal-title":"Front Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ijms19010088","volume":"19","author":"Alfadda A.","year":"2018","unstructured":"Alfadda A.; Benabdelkamel H.; Masood A.; Jammah A.; Ekhzaimy A.; Differences in the plasma proteome of patients with hypothyroidism before and after thyroid hormone replacement: A proteomic analysis. Int J Mol Sci  2018,19(1),88","journal-title":"Int J Mol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"808008","DOI":"10.3389\/fimmu.2021.808008","volume":"12","author":"Rekvig O.P.","year":"2022","unstructured":"Rekvig O.P.; The anti-DNA antibodies: Their specificities for unique DNA structures and their unresolved clinical impact\u2014A system criticism and a hypothesis. Front Immunol  2022,12,808008","journal-title":"Front Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1097\/MD.0000000000004336","volume":"95","author":"Elnady B.M.","year":"2016","unstructured":"Elnady B.M.; Kamal N.M.; Shaker R.H.M.; Soliman A.F.; Hasan W.A.; Alghamdi H.A.; Algethami M.M.; Jajah M.B.; Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases. Medicine  2016,95(38),4336","journal-title":"Medicine"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"10","author":"Wang X.","year":"2019","unstructured":"Wang X.; Xia Y.; Anti-double stranded DNA antibodies: Origin, pathogenicity, and targeted therapies. Front Immunol  2019,10,1667","journal-title":"Front Immunol"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037374562250730060143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244754\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037374562250730060143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:20:38Z","timestamp":1779528038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244754\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892037374562250730060143","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}